Spectrum Pharmaceuticals reported $-49921000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Actinium Pharmaceuticals ATNM:US $ -5021000 299K
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Astellas Pharma 4503:JP Y 35830M 54733M
Bayer BAYN:GR € 1537M 1825M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Endo International Ordinary Shares ENDP:US $ 181.61M 22.56M
GlaxoSmithKline GSK:LN 1482M 225M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Johnson & Johnson JNJ:US $ 7776M 515M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Novartis NOVN:VX SF 4424M 620M
Sanofi SAN:FP € 2180M 376M
Spectrum Pharmaceuticals SPPI:US $ -49.92M 14.24M
Teva Pharmaceutical TEVA:IT 794M 650M
Tg Therapeutics TGTX:US $ -78.5M 12.13M
YTE INCY:US $ 199.6M 31.06M